RCM
BIIB icon

Riverhead Capital Management’s Biogen BIIB Stock Holding History

Riverhead Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$12.6M Sell
54,118
-9,931
-16% -$2.31M 0.47% 35
2019
Q2 		$15M Sell
64,049
-20,719
-24% -$4.78M 0.55% 25
2019
Q1 		$20M Buy
84,768
+18,779
+28% +$5.91M 0.81% 8
2018
Q4 		$19.9M Sell
65,989
-3,912
-6% -$1.25M 0.89% 5
2018
Q3 		$24.7M Sell
69,901
-4,594
-6% -$1.58M 0.89% 7
2018
Q2 		$21.6M Buy
74,495
+8,684
+13% +$2.44M 0.85% 8
2018
Q1 		$18M Buy
65,811
+32,335
+97% +$10M 0.76% 13
2017
Q4 		$10.7M Buy
33,476
+11,858
+55% +$3.8M 0.45% 39
2017
Q3 		$6.77M Buy
21,618
+4,350
+25% +$1.29M 0.32% 75
2017
Q2 		$4.69M Buy
17,268
+8,340
+93% +$2.21M 0.23% 117
2017
Q1 		$2.44M Buy
8,928
+6,040
+209% +$1.71M 0.13% 221
2016
Q4 		$819K Sell
2,888
-2,900
-50% -$860K 0.05% 380
2016
Q3 		$1.81M Sell
5,788
-1,396
-19% -$413K 0.12% 227
2016
Q2 		$1.74M Sell
7,184
-10,176
-59% -$2.68M 0.06% 325
2016
Q1 		$4.52M Sell
17,360
-4,152
-19% -$1.1M 0.06% 342
2015
Q4 		$6.59M Sell
21,512
-2,329
-10% -$669K 0.1% 267
2015
Q3 		$6.96M Buy
23,841
+1,042
+5% +$344K 0.11% 261
2015
Q2 		$9.21M Buy
22,799
+291
+1% +$117K 0.14% 219
2015
Q1 		$9.5M Sell
22,508
-1,169
-5% -$461K 0.14% 216
2014
Q4 		$8.04M Buy
23,677
+1,113
+5% +$360K 0.12% 236
2014
Q3 		$7.46M Buy
22,564
+416
+2% +$137K 0.13% 230
2014
Q2 		$6.99M Buy
22,148
+4,299
+24% +$1.29M 0.13% 235
2014
Q1 		$5.46M Buy
17,849
+667
+4% +$212K 0.12% 234
2013
Q4 		$4.8M Buy
17,182
+5,182
+43% +$1.34M 0.13% 229
2013
Q3 		$2.89M Hold
12,000
– – 0.09% 247
2013
Q2 		$2.58M Buy
+12,000
New +$2.56M 0.09% 241

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Riverhead Capital Management's BIIB Position: Q3 2019 in Review

Riverhead Capital Management reduced its Biogen (BIIB) stake by 16% in Q3 2019, selling an estimated $2.31M and leaving 54,118 shares worth $12.6M. The position accounts for 0.47% of the portfolio, ranked #35.

Riverhead Capital Management first reported a position in BIIB in Q2 2013 and has held it in 26 quarters since. The position peaked at $24.7M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Riverhead Capital Management held 54,118 shares of Biogen worth $12.6M as of Q3 2019.
  • Riverhead Capital Management sold 9,931 Biogen shares in Q3 2019, an estimated $2.31M.
  • Biogen made up 0.47% of Riverhead Capital Management's portfolio in Q3 2019, its #35 holding.
  • Riverhead Capital Management first reported a position in Biogen in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Biogen position peaked at $24.7M in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.